
Merck KGaA is to promote its deputy chief executive Stefan Oschmann to replace Karl-Ludwig Kley in the top job next …
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine

